LifeVantage Statistics
Total Valuation
LifeVantage has a market cap or net worth of $303.61 million. The enterprise value is $302.38 million.
| Market Cap | 303.61M |
| Enterprise Value | 302.38M |
Important Dates
The next confirmed earnings date is Wednesday, February 5, 2025, after market close.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | Dec 2, 2024 |
Share Statistics
LifeVantage has 12.53 million shares outstanding. The number of shares has increased by 1.53% in one year.
| Current Share Class | 12.53M |
| Shares Outstanding | 12.53M |
| Shares Change (YoY) | +1.53% |
| Shares Change (QoQ) | -0.33% |
| Owned by Insiders (%) | 19.52% |
| Owned by Institutions (%) | 24.19% |
| Float | 8.50M |
Valuation Ratios
The trailing PE ratio is 75.86 and the forward PE ratio is 27.86.
| PE Ratio | 75.86 |
| Forward PE | 27.86 |
| PS Ratio | 1.53 |
| Forward PS | 1.89 |
| PB Ratio | 10.93 |
| P/TBV Ratio | 11.08 |
| P/FCF Ratio | 56.35 |
| P/OCF Ratio | 44.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.46, with an EV/FCF ratio of 56.12.
| EV / Earnings | 73.14 |
| EV / Sales | 1.54 |
| EV / EBITDA | 31.46 |
| EV / EBIT | 49.14 |
| EV / FCF | 56.12 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.48.
| Current Ratio | 1.76 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | 2.48 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.51% and return on invested capital (ROIC) is 9.10%.
| Return on Equity (ROE) | 14.51% |
| Return on Assets (ROA) | 6.01% |
| Return on Capital (ROIC) | 9.10% |
| Revenue Per Employee | $882,946 |
| Profits Per Employee | $18,622 |
| Employee Count | 222 |
| Asset Turnover | 3.06 |
| Inventory Turnover | 2.50 |
Taxes
In the past 12 months, LifeVantage has paid $1.97 million in taxes.
| Income Tax | 1.97M |
| Effective Tax Rate | 32.22% |
Stock Price Statistics
The stock price has increased by +331.32% in the last 52 weeks. The beta is 0.84, so LifeVantage's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +331.32% |
| 50-Day Moving Average | 17.29 |
| 200-Day Moving Average | 10.74 |
| Relative Strength Index (RSI) | 67.30 |
| Average Volume (20 Days) | 209,787 |
Short Selling Information
The latest short interest is 191,818, so 1.53% of the outstanding shares have been sold short.
| Short Interest | 191,818 |
| Short Previous Month | 202,762 |
| Short % of Shares Out | 1.53% |
| Short % of Float | 2.26% |
| Short Ratio (days to cover) | 2.00 |
Income Statement
In the last 12 months, LifeVantage had revenue of $196.01 million and earned $4.13 million in profits. Earnings per share was $0.32.
| Revenue | 196.01M |
| Gross Profit | 155.26M |
| Operating Income | 6.15M |
| Pretax Income | 4.19M |
| Net Income | 4.13M |
| EBITDA | 9.61M |
| EBIT | 6.15M |
| Earnings Per Share (EPS) | $0.32 |
Balance Sheet
The company has $14.60 million in cash and $13.36 million in debt, giving a net cash position of $1.23 million or $0.10 per share.
| Cash & Cash Equivalents | 14.60M |
| Total Debt | 13.36M |
| Net Cash | 1.23M |
| Net Cash Per Share | $0.10 |
| Equity (Book Value) | 27.70M |
| Book Value Per Share | 2.22 |
| Working Capital | 16.74M |
Cash Flow
In the last 12 months, operating cash flow was $6.85 million and capital expenditures -$1.46 million, giving a free cash flow of $5.39 million.
| Operating Cash Flow | 6.85M |
| Capital Expenditures | -1.46M |
| Free Cash Flow | 5.39M |
| FCF Per Share | $0.43 |
Margins
Gross margin is 79.21%, with operating and profit margins of 3.14% and 2.11%.
| Gross Margin | 79.21% |
| Operating Margin | 3.14% |
| Pretax Margin | 3.11% |
| Profit Margin | 2.11% |
| EBITDA Margin | 4.90% |
| EBIT Margin | 3.14% |
| FCF Margin | 2.75% |
Dividends & Yields
This stock pays an annual dividend of $0.16, which amounts to a dividend yield of 0.66%.
| Dividend Per Share | $0.16 |
| Dividend Yield | 0.66% |
| Dividend Growth (YoY) | 55.00% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 50.07% |
| Buyback Yield | -1.53% |
| Shareholder Yield | -0.87% |
| Earnings Yield | 1.36% |
| FCF Yield | 1.77% |
Analyst Forecast
The average price target for LifeVantage is $30.50, which is 25.83% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.50 |
| Price Target Difference | 25.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 19, 2015. It was a reverse split with a ratio of 0.1428571:1.
| Last Split Date | Oct 19, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.1428571:1 |
Scores
LifeVantage has an Altman Z-Score of 2.96 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.96 |
| Piotroski F-Score | 5 |